View more on these topics

Zurich pays out 94% of CI claims in 2013

Zurich paid 94 per cent of the critical illness claims it received last year, up from 90 per cent in 2012.

The provider paid out 806 claims in 2013, with payments totalling £65.2m. This compares to 744 in 2012, with payments totalling £59.9m.

Around 4.8 per cent of claims were declined due to the definition not being met, down from 7.9 per cent in 2012, while 1 per cent of claims were denied because of non-disclosure – the same as the previous year.

Some 60 per cent of payments were made for cancer claims. The next most common condition for claims paid was heart attack, at 13 per cent, followed by stroke and multiple sclerosis at 9 per cent and 5 per cent respectively.

Zurich European chief claims officer Rhys Dudding says: “There is a perception in the market that pay out rates for CI claims are low.  Our claims record shows  the vast majority of claims are settled successfully and swiftly with the amounts awarded growing each year.”  

Master Adviser senior partner Roy McLoughlin says: “The industry continues to move in the welcome direction of all genuine claims being paid out and these excellent figures enhance this vision of utopia that all customers desire and demand.”


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm